BULL PHARMA: EXPOSING THE CONTROVERSIES

The term " Disreputable Pharma" has emerged recently, igniting a heated controversy surrounding some pharmaceutical corporations . Allegations of deceptive marketing practices, inflated drug rates, and a potential disregard for patient safety have resulted in increasing scrutiny from regulators ,